CXCL2 and neoplasm: Furthermore, the differentiation of CXCR2−/− bone marrow progenitor cells into mo-MDSCs was markedly reduced compared with the WT mice in the serum of tumor-bearing mice or tumor-bearing mice supplemented with recombinant CXCL1 or CXCL2 (Fig. 2a, b).